Biotechnology

Techseriesinsight > Blog > News > Biotechnology

April 16, 2026
Business Wire
Biotechnology, News

GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026

A leader in plasma-derived products, today announced the presentation of new research evaluating the aggregation profiles, including molecular size distribution and particle size, in commercially available intravenous immunoglobulin (IVIG)...

April 15, 2026
Business Wire
Biotechnology, News

New Canadian Bio-Economy AI Course Launched

Today, BioTalent Canada and Propero Learning Systems launched AI Fundamentals for the Bio-economy, a new foundational Artificial Intelligence training course geared to small and medium-sized companies in Canada’s bio-economy....

April 14, 2026
PRNewswire
Biotechnology, News

The Deerborne Group to Attend American Association for Cancer Research (AACR) Annual Meeting

The Deerborne Group, a boutique consultancy focused exclusively on genomics and precision diagnostics, will attend the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22, 2026,...

April 6, 2026
PRNewswire
Biotechnology, News

25th Annual Bio-IT World Conference & Expo in Boston Leads the Conversation on Operationalizing AI Across Real-World Drug Discovery Environments

Bio-IT World 2026, taking place May 19-21 in Boston and virtually, is the premier global event uniting more than 2,900 leaders from biopharma, biomedical research, bioinformatics, and IT to...

March 23, 2026
PRNewswire
Biotechnology, News

Dimer Health Raises $13.5 Million To Rebuild Post-Discharge Care With Clinician-Led AI

Dimer Health, a clinician-led, AI-native Transitional Care Medicine company, today announced $13.5 million in Series A financing led by Team8 and Bill Ackman’s Table Management, with participation from existing...

March 20, 2026
Business Wire
Biotechnology, News

IntraBio Announces Submission of Supplemental New Drug Application for Levacetylleucine for Ataxia-Telangiectasia

IntraBio Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for levacetylleucine for the treatment of Ataxia-Telangiectasia (A-T),...

March 20, 2026
PRNewswire
Biotechnology, News

Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients

A leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, published a study in JAMA Network Open, titled “An AI Approach to Differentiating Lung Squamous Cell Carcinoma From...

March 19, 2026
Business Wire
Biotechnology, News

Shionogi Announces First Patients Enrolled in Global Phase 2 Clinical Trial in Adults with Late-Onset Pompe Disease

Announced the first patients were enrolled in Esprit, a global Phase 2 clinical trial evaluating, an investigational drug for the treatment of late-onset Pompe disease (LOPD). Esprit is a multicenter,...

Hippocratic AI Announces New Senior Executive Appointments

March 18, 2026
PRNewswire
Biotechnology, News

Diakonos Oncology to Showcase DOC1021 (dubodencel) Clinical Data in Pancreatic Cancer and Glioblastoma at AACR and ANN 2026

A clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, announced today that the Company will present new clinical trial data at the...

March 17, 2026
Business Wire
Biotechnology, News

DNA Script Expands Global Access to On-demand DNA Synthesis With Distributor Agreements in Latin America and East Asia

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co. (BMS), and Biostream, expanding global...